Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZNF536 Inhibitors

ZNF536 inhibitors belong to a specialized category of chemical compounds designed to target and modulate the activity of ZNF536, which stands for Zinc Finger Protein 536. ZNF536 is a member of the zinc finger protein family, a group of transcription factors known for their ability to bind to specific DNA sequences and regulate gene expression. These proteins play pivotal roles in various cellular processes, including development, differentiation, and response to environmental signals. ZNF536, in particular, contains multiple zinc finger motifs that enable it to interact with DNA in a sequence-specific manner. Inhibitors of ZNF536 are developed to interact with this specific transcription factor, influencing its DNA binding properties, its interactions with other cellular proteins, or its roles in regulating gene expression.

Structurally, ZNF536 inhibitors are meticulously designed to engage specific regions or binding sites on the ZNF536 protein, primarily targeting its zinc finger domains. This interaction may disrupt the normal functioning of ZNF536, affecting its ability to bind to DNA and modulate the transcription of target genes. The mechanisms by which ZNF536 inhibitors exert their effects can vary, but their primary objective is to serve as valuable tools for researchers studying the roles of ZNF536 in various cellular contexts. Investigating the biochemical and functional aspects of ZNF536 and its modulation by inhibitors can contribute to a deeper understanding of gene regulation, cellular differentiation, and the broader field of molecular and cellular biology. Ultimately, such research can offer insights into the intricate molecular mechanisms that govern fundamental cellular processes and their regulation by ZNF536 inhibition.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine inhibits DNA methyltransferases, leading to DNA demethylation. Demethylated DNA can reactivate silenced genes, possibly influencing ZNF536 expression.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

JQ1 inhibits BET bromodomains. By inhibiting bromodomains, it affects the reading of acetylated histones, which can alter the transcription of certain genes, possibly including ZNF536.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

RG108, a DNA methyltransferase inhibitor, can change DNA methylation patterns and influence gene expression, possibly impacting ZNF536 expression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Decitabine inhibits DNA methyltransferases and can alter gene expression by changing DNA methylation patterns, which could influence ZNF536.

Mocetinostat

726169-73-9sc-364539
sc-364539B
sc-364539A
5 mg
10 mg
50 mg
$214.00
$247.00
$1463.00
2
(1)

Mocetinostat is an HDAC inhibitor that can change gene expression profiles in cells, possibly affecting ZNF536.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$218.00
$634.00
1
(1)

Romidepsin inhibits HDACs. Its influence on histone acetylation can lead to changes in gene transcription, which may include effects on ZNF536.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

Entinostat is an HDAC inhibitor. By influencing histone acetylation, it can modulate the transcription of various genes, potentially impacting ZNF536 expression.

Panobinostat

404950-80-7sc-208148
10 mg
$200.00
9
(1)

Panobinostat, another HDAC inhibitor, can influence gene expression through its effects on histone acetylation, which may impact ZNF536.

EPZ6438

1403254-99-8sc-507456
1 mg
$66.00
(0)

Tazemetostat inhibits the histone methyltransferase EZH2. By influencing histone methylation, it can affect transcription, which might include effects on ZNF536.

GSK126

1346574-57-9sc-490133
sc-490133A
sc-490133B
1 mg
5 mg
10 mg
$92.00
$243.00
$306.00
(0)

GSK126, an EZH2 inhibitor, can alter histone methylation patterns, potentially influencing the expression of genes, possibly including ZNF536.